• Careers
  • Call Us Now: +1 (737) 787-4313

Benuvia | Controlled Substance Solutions

Menu
  • Controlled Substance Experts
  • Unified Services
    • API Process Development
    • Analytical Development
    • Formulation Development
    • Manufacturing Services
    • Regulatory Services
    • Commercial Services
  • Specialized Solutions
    • Discovery Booster
    • Clinical Expressway
    • Market Accelerator
    • Stability Solutions
  • Our Company
    • Company News
    • Company Events
    • Careers
  • Knowledge Center
    • Case Studies
    • Whitepapers
  • Company News

    Benuvia Operations Signs Research & Development and Manufacturing Agreement with Trait Biosciences to Advance Next-Generation Cannabinoid-Based Products

    ROUND ROCK, Texas, May 6, 2025 – Benuvia Operations, LLC (Benuvia), a global contract development...

    Read More
  • Company News

    Benuvia Operations, LLC Enters into Licensing Agreement with Avernus Pharma for SYNDROS® CII (dronabinol) in the Gulf Cooperation Council Region

    ROUND ROCK, Texas, December 10, 2024 – Benuvia Operations, LLC, a global contract development...

    Read More
  • Company News

    Benuvia Operations, LLC Enters into Licensing and Supply Agreements with Medra Brasil Medicamentos LTDA

    Supply agreement will support the development of new Medra Brasil CBD products ROUND ROCK, Texas,...

    Read More
  • Company News

    Benuvia Operations, LLC and Department of Veterans Affairs Sign CRADA Agreement

    ROUND ROCK, Texas, November 13, 2024 – Benuvia Operations, LLC (“Benuvia”), an FDA...

    Read More
  • Company News

    Benuvia Appoints Terry Novak as New CEO

    Mr. Novak brings three decades of executive leadership experience in the pharmaceutical, biotech,...

    Read More
  • Company News

    House passes Biosecure Act, sending Chinese biotech ban to Senate

    The US House of Representatives on Monday evening passed the Biosecure Act with broad bipartisan...

    Read More
  • Company News

    Benuvia Operations, LLC Partners with Bright Green Corporation to Secure DEA-Approved Raw Materials for Pharmaceutical Innovation

    ROUND ROCK, TEXAS, August 21, 2024 –Benuvia Operations, LLC, a leader in the development of...

    Read More
  • Company News

    Strategic Partnership to Advance Healthcare Solutions

    Austin, Texas — February 26, 2024 — Benuvia Operations, LLC (“Benuvia”), a leader in...

    Read More
  • Company News

    Societal CDMO and Benuvia Sign Co-marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers

    Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing...

    Read More
  • Company News

    Benuvia and PharmaCielo Strategic Partnership

    AUSTIN, Texas, U.S.A., TORONTO, Canada and RIONEGRO, Colombia (January 3, 2024) Benuvia Operations,...

    Read More
  • Unified Services
    • Formulation Development
    • API Synthesis
    • Analytical Development
    • Regulatory
    • Manufacturing
    • Commercialization
  • Specialized Solutions
    • Discovery Booster
    • Clinical Expressway
    • Market Accelerator
    • Stability Solutions
  • Our Company
    • Controlled Substance Experts
    • Company News
    • Company Events
    • Careers
  • Knowledge Center
    • Case Studies
    • Whitepapers
Benuvia | Controlled Substance Solutions

3950 N. Mays Street | Round Rock, TX 78665
Main Telephone Line: (512) 543-1569

  • Privacy Policy
  • Terms of Service
Copyright © 2025 Benuvia Operations, LLC

  • Follow us on LinkedIn